Stopping
cancer requires understanding the patient’s tumor expression
Stopping cancer requires
new targets
Stopping
cancer requires new therapies and new combinations
Stopping cancer
is our mission
Sirexatamab
(DKN-01)
– an anti-DKK1 antibody
